HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ASA Reinforces That Exceptions To Influencer #Ad Requirements Are Hard To Come By

This article was originally published in The Rose Sheet

Executive Summary

The Advertising Standards Authority rejects brand ambassador Olivia Buckland’s argument that a May Instagram post touting W7 eyeshadows did not require a disclosure because she wasn’t acting on a specific request or contractual obligation with the company.

You may also be interested in...



Pregnant TV Star's Weight Loss Claim On Instagram Tips UK Regulatory Scale

UK Advertising Standards Authority assessment concludes Instagram post by reality star and social media influencer violated UK ad codes because it did not identify as an ad, pushed weight loss products on pregnant women and made weight loss claims for food products.

Sanofi Warned Over Use Of Social Media Influencer For UK Ad Campaign

Sanofi's decision to promote its Phenergan sleep-aid through a social media influencer - even one with a relatively small following - was tantamount to a celebrity endorsement, says the UK's advertising regulator.

UK Authority Launches Probe Into Social Influencer Disclosure Practices

The Competition and Markets Authority could pursue enforcement action based on findings from its investigation into leading social media influencers’ promotional activities, announced Aug. 16. The Federal Trade Commission has been focused increasingly on similar issues in the US.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel